Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems

Medicine (United States)

Volumn 96, Issue 34, 2017, Pages

  Meng, Ze Wu ^a   Pan, Wei ^a   Hong, Hai Jie ^a   Chen, Jiang Zhi ^a   Chen, Yan Ling ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

clinicopathological characteristics; intrahepatic cholangiocarcinoma; prognosis; TNM staging

Indexed keywords

ADJUVANT RADIOTHERAPY; ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; BLACK PERSON; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; PRIORITY JOURNAL; ADOLESCENT; AGED; BILE DUCT TUMOR; CANCER REGISTRY; INCIDENCE; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; YOUNG ADULT;

EID: 85028708265     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000007891     Document Type: Article

References (30)

1. West J, Wood H, Logan RF, et al. Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006; 94: 1751-8.
2. Welzel TM, McGlynn KA, Hsing AW, et al. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intraand extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006; 98: 873-5.
3. Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29: 221-32.
4. Zhang H, Yang T, Wu M, et al. Intrahepatic cholangiocarcinoma: epidemiology, risk factors, diagnosis and surgical management. Cancer Lett 2016; 379: 198-205.
5. Meng ZW, Han SH, Zhu JH, et al. Risk factors for cholangiocarcinoma after initial hepatectomy for intrahepatic stones. World J Surg 2017; 41: 835-43.
6. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag. 2002.
7. Inoue K, Makuuchi M, Takayama T, et al. Long-Term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127: 498-505.
8. Edge SB. American Joint Committee on Cancer; ACSAJCC Cancer Staging Manual. 7th ed.Springer, New York: 2009.
9. Nathan H, Aloia TA, Vauthey JN, et al A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 2009; 16: 14-22.
10. Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 2010; 26: 269-73.
11. Jiang W, Zeng ZC, Tang ZY, et al A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score. Ann Oncol 2011; 22: 1644-52.
12. Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group. Cancer 2011; 117: 2170-7.
13. Li T, Qin LX, Zhou J, et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver Int 2014; 34: 953-60.
14. Ali SM, Clark CJ, Mounajjed T, et al. Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB 2015; 17: 244-50.
15. National Cancer Institute. SEER: Surveillance, Epidemiology, and End Results Program. Available at: http://seer.cancer.gov. Accessed November, 2014.
16. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
17. Cho YK, Chung JW, Kim JK, et al. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Cancer 2008; 112: 352-61.
18. Yoon HM, Ryu KW, Nam BH, et al. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer? J Am Coll Surg 2012; 214: 88-96.
19. Harrell FEJr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
20. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29: 3140-5.
21. Mavros MN, Economopoulos KP, Alexiou VG, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-Analysis. JAMA Surg 2014; 149: 565-74.
22. Luo X, Yuan L, Wang Y, et al. Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study. J Gastrointest Surg 2014; 18: 562-72.
23. Hammad AY, Berger NG, Eastwood D, et al. Is radiotherapy warranted following intrahepatic cholangiocarcinoma resection? The impact of surgical margins and lymph node status on survival. Ann Surg Oncol 2016; 23(suppl 5): 912-20.
24. Mahadevan A, Dagoglu N, Mancias J, et al. Stereotactic body radiotherapy (SBRT) for intrahepatic and hilar cholangiocarcinoma. J Cancer 2015; 6: 1099-104.
25. Uno M, Shimada K, Yamamoto Y, et al. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass. Surg Today 2012; 42: 1189-94.
26. Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA Cancer J Clin 2017; 67: 93-9.
27. Yamasaki S. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepatobiliary Pancreat Surg 2003; 10: 288-91.
28. Hirohashi K, Uenishi T, Kubo S, et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002; 49: 326-9.
29. Sanada Y, Kawashita Y, Okada S, et al. Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma. World J Gastrointest Pathophysiol 2014; 5: 188-99.
30. Ariizumi S, Yamamoto M. [Surgical treatment of intrahepatic cholangiocarcinoma based on the macroscopic subtype]. Nihon Shokakibyo Gakkai Zasshi 2012; 109: 1885-94.